MYLK and ovarian carcinoma: To evaluate these findings in clinical specimens, a tissue microarray containing 144 epithelial ovarian cancer cases was stained with anti‐SIK2 and anti‐MYLK‐pS343 antibodies for immunohistochemical analysis (Fig. 6D and Table. S1).